Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesTreating refractory asthma with antibodies against IL-5: is it ready for prime time
Expert Review of Respiratory Medicine, 06/18/09
Ahmad F et al. - The current prospective study evaluates the effectiveness of mepolizumab, an agent that targets IL-5, which is a mediator of eosinophilia in patients with refractory asthma and sputum eosinophilia. The study shows that this treatment reduced eosinophilia and was associated with a significant reduction in asthma exacerbations.
Today in Asthma/Atopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-inflammatory drug therapy in asthma
Paediatric Respiratory Reviews, 11/02/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Sponsor
Article Search
Sponsor